BMC Geriatrics | |
Radical cystectomy over the age of 75 is safe and increases survival | |
Constantinos A Constantinides1  Dionysios Mitropoulos1  Ioannis Leotsakos1  Ioannis Katafigiotis1  Antonios Balangas3  Anastasios Kollias3  Aristeides Alevizopoulos1  Konstantinos G Stravodimos1  Ioannis Anastasiou1  Stavros I Tyritzis2  | |
[1] Department of Urology, Athens University Medical School, LAIKO Hospital, Athens, Greece;Department of Urology, Athens University Medical School, LAIKO Hospital, 17 Agiou Thoma str., Athens 11527, Greece;Department of Urology, Ammerland Clinics, Westerstede, Germany | |
关键词: Charlson comorbidity index; Clavien classification system; Survival; Complications; Octogenarians; Radical cystectomy; | |
Others : 858133 DOI : 10.1186/1471-2318-12-18 |
|
received in 2011-11-22, accepted in 2012-04-30, 发布年份 2012 | |
【 摘 要 】
Background
Radical cystectomy (RC) is probably underused in elderly patients due to a potential increased postoperative complication risk, as reflected by their considerable comorbidities. Our objective was to estimate the overall complication rate and investigate a potential benefit to patients over the age of 75 subjected to RC in terms of disease-free survival.
Methods
A total of 81 patients, 61 men and 20 women, from two urological departments, with a mean age of 79.2 ± 3.7 years, participated in the study. The mean follow-up period was 2.6 ± 1.6 years. All patients underwent RC with pelvic lymphadenectomy. An ileal conduit, an orthotopic ileal neobladder and cutaneous ureterostomies were formed in 48.1%, 6.2% and 45.7% of the patients, respectively. The perioperative and 90-day postoperative complications were recorded and classified according to the modified Clavien classification system. Survival plots were created based on the oncological outcome and several study parameters.
Results
The perioperative morbidity rate was 43.2%; the 90-day morbidity rate was 37%, while the 30-day, 90-day and overall mortality rates were 3.7%, 3.7% and 21%, respectively. Overall mortality rates were recorded at the final year of data gathering (2009). Increased age, increased body mass index (BMI), longer hospitalization and age-adjusted Charlson comorbidity index (ACCI) more than six, were associated with greater hazard for 90-day morbidity. The cumulative mortality / metastasis-free rates for one, two, three and five years were 88.7%, 77.5%, 70.4%, and 62.3%, respectively. Tumour stage and positive nodes were prognostic predictors for oncological outcome.
Conclusions
RC in patients over 75 is justified and feasible, due to acceptable complication rates and high 5-year cancer-specific survival, which support an aggressive approach. Prospective studies are needed for the verification of the above results.
【 授权许可】
2012 Tyritzis et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140723093624334.pdf | 245KB | download | |
31KB | Image | download | |
24KB | Image | download | |
24KB | Image | download |
【 图 表 】
【 参考文献 】
- [1]Jemal A, Clegg LX, Ward E, et al.: Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004, 101:3-27.
- [2]Clark PE, Stein JP, Groshen SG, et al.: Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer 2005, 104:36-43.
- [3]Stenzl A, Cowan NC, De Santis M, et al.: The updated EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2009, 55:815-825.
- [4]Hollenbeck BK, Miller DC, Taub D, et al.: Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004, 64:292-297.
- [5]Wehrberger C, Berger I, Marszalek M, et al.: Bladder preservation in octogenarians with invasive bladder cancer. Urology 2010, 75:370-375.
- [6]Martin RC, Brennan MF, Jaques DP: Quality of complication reporting in the surgical literature. Ann Surg 2002, 235:803-813.
- [7]Dindo D, Demartines N, Clavien PA: Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240:205-213.
- [8]Hall WH, Ramachandran R, Narayan S, Jani AB, Vijayakumar S: An electronic application for rapidly calculating Charlson comorbidity score. BMC Cancer 2004, 4:94. BioMed Central Full Text
- [9]Koppie TM, Serio AM, Vickers AJ, et al.: Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer. Cancer 2008, 112:2384-2392.
- [10]Boström PJ, Kössi J, Laato M, Nurmi M: Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2009, 103:191-196.
- [11]Froehner M, Brausi MA, Herr HW, Muto G, Studer UE: Complications following radical cystectomy for bladder cancer in the elderly. Eur Urol 2009, 56:443-454.
- [12]Shabsigh A, Korets R, Vora KC, et al.: Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009, 55:164-176.
- [13]Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PMT, Harrison SCW: A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 2003, 43:246-257.
- [14]Crawford ED, Skinner DG: Salvage cystectomy after irradiation failure. J Urol 1980, 123:32-34.
- [15]Smith JA, Whitmore WF: Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol 1981, 125:643-645.
- [16]Sogni F, Brausi M, Frea B, et al.: Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology 2008, 71:919-923.
- [17]Barbieri CE, Lee B, Cookson MS, et al.: Association of procedure volume with radical cystectomy outcomes in a nationwide database. J Urol 2007, 178:1418-1421.
- [18]Nielsen ME, Shariat SF, Karakiewicz PI, et al.: Bladder Cancer Research Consortium (BCRC). Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur Urol 2007, 5:699-706.
- [19]Resorlu B, Beduk Y, Baltaci S, Ergun G, Talas H: The prognostic significance of advanced age in patients with bladder cancer treated with radical cystectomy. BJU Int 2009, 103:480-483.
- [20]Chamie K, Hu B, Devere White RW, Ellison LM: Cystectomy in the elderly: does the survival benefit in younger patients translate to the octogenarians? BJU Int 2008, 102:284-290.
- [21]Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF: Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1994, 73:1708-1715.